Dali Pharmaceuticalco.Ltd Balance Sheet Health
Financial Health criteria checks 3/6
Dali Pharmaceuticalco.Ltd has a total shareholder equity of CN¥361.4M and total debt of CN¥19.3M, which brings its debt-to-equity ratio to 5.4%. Its total assets and total liabilities are CN¥450.2M and CN¥88.8M respectively.
Key information
5.4%
Debt to equity ratio
CN¥19.34m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥207.69m |
| Equity | CN¥361.39m |
| Total liabilities | CN¥88.81m |
| Total assets | CN¥450.20m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 603963's short term assets (CN¥273.3M) exceed its short term liabilities (CN¥77.3M).
Long Term Liabilities: 603963's short term assets (CN¥273.3M) exceed its long term liabilities (CN¥11.5M).
Debt to Equity History and Analysis
Debt Level: 603963 has more cash than its total debt.
Reducing Debt: 603963's debt to equity ratio has increased from 0% to 5.4% over the past 5 years.
Debt Coverage: 603963's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 603963's interest payments on its debt are well covered by EBIT.